Tipe2 | List of Frontiers open access articles

Original Research

Published on 23 Jun 2021

TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway

in Cancer Molecular Targets and Therapeutics

Fang Feng
Chunliang Liu
Huahui Bian
Wei Cai
Ying Zhou
Li Zhou
Zhixiang Zhuang

Frontiers in Oncology

doi 10.3389/fonc.2021.680985

4,401 views
13 citations

Original Research

Published on 24 Sep 2021

Beneficial Effects of Gracillin From Rhizoma Paridis Against Gastric Carcinoma via the Potential TIPE2-Mediated Induction of Endogenous Apoptosis and Inhibition of Migration in BGC823 Cells

in Pharmacology of Anti-Cancer Drugs

Wenming Liu
Yanting Wang
Junjie Chen
Zhenhe Lin
Mengjie Lin
Xiantong Lin
Yanyun Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.669199

3,686 views
18 citations

Original Research

Published on 19 Mar 2021

Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages

in Viral Immunology

Ziqi Zou
Mengyao Li
Yunlian Zhou
Jiaying Li
Ting Pan
Lihua Lai
Qingqing Wang
Lining Zhang
Qun Wang
Yinjing Song

Frontiers in Immunology

doi 10.3389/fimmu.2021.642715

5,389 views
8 citations

Original Research

Published on 28 Apr 2022

TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma

in Inflammation

Bingqing Shi
Yuqiu Hao
Wei Li
Hongna Dong
Mengting Xu
Peng Gao

Frontiers in Immunology

doi 10.3389/fimmu.2022.883885

7,851 views
23 citations

Original Research

Published on 23 Nov 2021

An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2

in Experimental Pharmacology and Drug Discovery

Haiping Zhang
Junxin Li
Konda Mani Saravanan
Hao Wu
Zhichao Wang
Du Wu
Yanjie Wei
Zhen Lu
Youhai H. Chen
Xiaochun Wan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772296

8,576 views
35 citations

Original Research

Published on 29 Apr 2022

TLR2/TLR4-Enhanced TIPE2 Expression Is Involved in Post-Hemorrhagic Shock Mesenteric Lymph-Induced Activation of CD4+T Cells

in T Cell Biology

Hui-Bo Du
Sun-Ban Jiang
Zhen-Ao Zhao
Hong Zhang
Li-Min Zhang
Zhao Wang
Ya-Xiong Guo
Jia-Yi Zhai
Peng Wang
Zi-Gang Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2022.838618

3,961 views
4 citations

Original Research

Published on 24 Sep 2019

Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases

in Autoimmune and Autoinflammatory Disorders

Ruiling Liu
Xiaozhen He
Wenwen Geng
Ting Wang
Qingguo Ruan

Frontiers in Immunology

doi 10.3389/fimmu.2019.02284

4,711 views
7 citations

Articles

TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway

Beneficial Effects of Gracillin From Rhizoma Paridis Against Gastric Carcinoma via the Potential TIPE2-Mediated Induction of Endogenous Apoptosis and Inhibition of Migration in BGC823 Cells

Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages

TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma

An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2

TLR2/TLR4-Enhanced TIPE2 Expression Is Involved in Post-Hemorrhagic Shock Mesenteric Lymph-Induced Activation of CD4+T Cells

Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases